506MO A Phase I Dose-Expansion Cohort of SYHA1813, a Vascular Endothelial Growth Factor Receptor (VEGFR) 1-3 /Colony-Stimulating Factor 1 Receptor (CSF1R) Inhibitor, in Patients (pts) with Recurrent Meningioma
Annals of Oncology（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要